3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
11
Rectal Neoplasms
5
Colorectal Neoplasms
5
Stomach Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Spinocerebellar Degenerations
1
Solid Tumor
1
Resectable NSCLC
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Meningeal Carcinomatosis
1
MSI-H
1
Lymphoma, T-Cell, Peripheral
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Interventions
pembrolizumab
60
Cisplatin
43
Cetuximab
25
Carboplatin
24
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy, Intensity-Modulated
17
Nivolumab
16
Radiotherapy
15
Specimen Handling
14
Docetaxel
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Taxes
8
Fluorouracil
8
Biopsy
7
atezolizumab
6
Radiation
6
(225)Ac-DOTA-c(RGDyK)
6
dostarlimab
5
cemiplimab
5
Ipilimumab
5
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
sintilimab
×
90 days
×
Clear all
No trials found.